Literature DB >> 20218623

Emerging targets in osteoporosis disease modification.

John G Allen1, Christopher Fotsch, Philip Babij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20218623     DOI： 10.1021/jm9018756

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  4 in total

1.  A role for the tyrosine kinase Pyk2 in depolarization-induced contraction of vascular smooth muscle.

Authors:  Ryan D Mills; Mitsuo Mita; Jun-ichi Nakagawa; Masaru Shoji; Cindy Sutherland; Michael P Walsh
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

2.  Newer anabolic therapies in osteopororsis.

Authors:  Monika Mittal; Naibedya Chattopadyay
Journal:  Indian J Endocrinol Metab       Date:  2012-12

3.  Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling.

Authors:  Radu M Suciu; Armand B Cognetta; Zachary E Potter; Benjamin F Cravatt
Journal:  ACS Med Chem Lett       Date:  2018-05-26       Impact factor: 4.345

Review 4.  Advances in the discovery of cathepsin K inhibitors on bone resorption.

Authors:  Jun Lu; Maolin Wang; Ziyue Wang; Zhongqi Fu; Aiping Lu; Ge Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.